Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial
Volume: 8, Issue: 3, Pages: 711 - 715
Published: Feb 23, 2021
Abstract
The CHORDS trial evaluated ocrelizumab (OCR) in patients with relapsing-remitting multiple sclerosis who had a suboptimal response to previous disease-modifying treatment. The objective of the present study was to assess the safety of shorter OCR infusions in a substudy of CHORDS. After completing four doses of OCR per initial US prescribing recommendations in the main study, participants in the substudy (N = 129) received a fifth dose over a...
Paper Details
Title
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial
Published Date
Feb 23, 2021
Volume
8
Issue
3
Pages
711 - 715
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History